Infection prevention solutions provider Bactiguard has collaborated with Quintess Medical and GS Medical to launch its wound care products in the UK and Ireland. The company’s wound care range includes biocompatible and effective wound care products that are pH-neutral and support an improved wound healing process. The Bactiguard product line is also environmentally friendly and non-toxic, and can be used for both acute and chronic wounds.
Market Value of Wound Care in the UK
According to a report, the market for wound care in the UK was valued at around GBP 860 million in 2022 and is expected to grow over the coming years. The aggregated annual cost of wound management in the UK is approximately GBP 8.3 billion, of which 67 percent is spent on managing unhealed wounds. Hard-to-heal wounds and chronic wounds, such as foot ulcers related to diabetes, create patient suffering and staggering costs for the healthcare systems.
Fight Against Antimicrobial Resistance
Patients with chronic wounds are more susceptible to multi-resistant bacteria, and as they receive more antibiotics, the risk of antimicrobial resistance is further increased. With Bactiguard’s wound care products, patients can receive enhanced quality of life while also fighting antimicrobial resistance. Bactiguard CEO Anders Göransson said that entering the UK and Ireland markets is a significant milestone for the company, and the markets present a great opportunity for the company.
The Importance of Effective Wound Cleaning System
Bactiguard’s wound care products provide a safe, effective, and environmentally sound solution for wound cleaning, which will accelerate and improve healing, and ultimately save healthcare budgets. By becoming an official agent for Bactiguard wound care, Quintess Medical can combine its local healthcare knowledge with Bactiguard’s wound care line to provide a highly effective wound cleaning system. The collaboration between Bactiguard, Quintess Medical, and GS Medical will not only bring Bactiguard’s Wound Care product range to more patients and end-users but also strengthen the company’s position in the wound care market.
Conclusion
In summary, Bactiguard’s launch of its wound care product range in the UK and Ireland is a significant milestone for the company, and the markets present a great opportunity. With the growing demand for wound care products in the UK, Bactiguard’s wound care products will provide a safe, effective, and environmentally sound solution to accelerate and improve healing. Through the collaboration with Quintess Medical and GS Medical, Bactiguard’s wound care products will be available to more patients and end-users, and the company’s position in the wound care market will be further strengthened.
